BlackRock Finance, Inc. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 107 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2024. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2024$15,437,635
-40.3%
4,436,102
+9.4%
0.00%
-100.0%
Q1 2024$25,876,769
+196.5%
4,055,920
+199.3%
0.00%
Q4 2023$8,728,383
+388.3%
1,355,339
+76.7%
0.00%
Q3 2023$1,787,336
-13.8%
767,097
-11.9%
0.00%
Q2 2023$2,072,966
+27.2%
870,994
-1.6%
0.00%
Q1 2023$1,629,315
+108.0%
885,497
+114.8%
0.00%
Q4 2022$783,275
-18.1%
412,250
-7.7%
0.00%
Q3 2022$956,000
-27.8%
446,855
-4.5%
0.00%
Q2 2022$1,325,000
-17.8%
467,846
+21.0%
0.00%
Q1 2022$1,612,000
-34.2%
386,714
-18.0%
0.00%
Q4 2021$2,448,000
+149.0%
471,733
+214.5%
0.00%
Q3 2021$983,000
+170.1%
149,972
+173.5%
0.00%
Q2 2021$364,000
-78.7%
54,841
-81.6%
0.00%
Q1 2021$1,705,000
-36.5%
297,605
-0.9%
0.00%
Q4 2020$2,684,000
-29.3%
300,260
-7.9%
0.00%
Q3 2020$3,795,000
-32.4%
326,090
-6.8%
0.00%
Q2 2020$5,611,000
+312.9%
350,046
+54.3%
0.00%
Q1 2020$1,359,000
-57.5%
226,867
-6.5%
0.00%
Q4 2019$3,201,000
-0.4%
242,510
-6.3%
0.00%
Q3 2019$3,213,000
-0.6%
258,724
+28.8%
0.00%
Q2 2019$3,234,000
-45.7%
200,872
+6.2%
0.00%
Q1 2019$5,951,000
-10.7%
189,070
-6.8%
0.00%
Q4 2018$6,666,000
+4314.6%
202,973
+4011.3%
0.00%
Q3 2018$151,000
+14.4%
4,9370.0%0.00%
Q2 2018$132,0004,9370.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2024
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders